Trial Profile
Efficacy and safety study of vWF SD-35-DH (WILFACTIN) in children under 6 years of age
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Aug 2015
Price :
$35
*
At a glance
- Drugs Von Willebrand factor (Primary)
- Indications Von Willebrand disease
- Focus Therapeutic Use
- Sponsors LFB Biotechnologies
- 13 Aug 2015 New trial record